Armistice Capital’s CVS Health CVS Stock Holding History

Armistice Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,250,000	Closed	-$74.9M	–	67
2019 Q1	$74.9M	Buy	1,250,000 +1,050,000	+525%	+$64.8M	4.1%	3
2018 Q4	$13.1M	Buy	+200,000	New	+$14.9M	0.99%	24

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Armistice Capital's CVS Position: Q1 2026 in Review

Armistice Capital sold out of CVS Health (CVS) in Q1 2026, closing a stake of 295,589 shares — an estimated $23.5M sold.

Armistice Capital first reported a position in CVS in Q4 2017 and held it in 13 quarters. The position peaked at $44.4M in Q4 2022. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Armistice Capital reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
Armistice Capital sold 295,589 CVS Health shares in Q1 2026, an estimated $23.5M.
Armistice Capital first reported a position in CVS Health in Q4 2017 and held it in 13 quarters.
Armistice Capital's CVS Health position peaked at $44.4M in Q4 2022.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.